Medical Policy

Policy Num:       10.001.014
Policy Name:     Telemedicine
Policy ID:          [10.001.014]  [Ac / L / M+ / P-]  [0.00.00]


Last Review:       October 24, 2024
Next Review:      October 20, 2025

 

Related Policies: None

TELEMEDICINE

Popultation Reference No. Populations Interventions Comparators Outcomes

1

Individuals:
  • All populations
Interventions of interest are:
  • Telemedicine consultation
Comparators of interest are:
  • Standard in-person consultation

Relevant outcomes include:

  • Overall quality of care
  • Quality of life
  • Patient Satisfaction
     

Summary

Telemedicine is defined as the exchange of medical information between the sites through electronic communication to transmit clinical information. The terms "telemedicine" and "telehealth" are used interchangeably, although "telehealth" is intended to include a wider range of services such as videoconferencing and transmission of still images. One of the advantages is increasing the participation of people who are medically or socially vulnerable or who do not have easy access to providers. Likewise, remote access helps preserve the relationship between the patient and the provider at times when the in-person consultation is not practical or feasible. Themain proposed advantage of telehealth is the ability to offer medical services to distant areas with little or no access to medical specialists.

Objective

Telehealth and Telemedicine programs assist healthcare providers in treating people who need access to their physician and cannot readily achieve an in person consultation.

Policy Statements

Numerous states have enacted laws regarding coverage of health care services delivered through telemedicine for either private insurers, the state Medicaid plan, or both. States have defined "telemedicine" generally as the delivery of health care services such as diagnosis, consultation, or treatment through the use of interactive audio, video, or other electronic media and do not include the sole use of an audio-only telephone, a video-only system, a facsimile machine, instant messages, or electronic mail. Communication consisting of emails, sole telephone conversations and facsimile transmission do not constitute as telemedicine consultation services.  Correct codes for place of services (2) must be used. Prior contracting must have been negotiated with provider.
 

Policy Guidelines

These services may be offered to our insureds and members by phone or electronic devices from March 6, 2020 for Medicare Advantage, March 15, 2020 for Commercial and March 17, 2020 for PSG (Plan Vital), until the emergency declaration is suspended or the applicable regulator notifies otherwise.

These measures ease the requirements necessary to use technological mechanisms to make consultations and evaluations of patient management remotely to avoid physical contact between the patient and the provider during the emergency.

Preparing for the telemedicine visit – Before the telemedicine visit, preparation should be done to anticipate and manage patient expectations as well as ensure the technology required for a successful telemedicine visit is functioning and accessible. Key points are to confirm technological requirements, obtain consent, discuss reimbursement and copay responsibilities, and discuss privacy expectations.

Providers should prepare the workspace for an effective video visit in advance and test audio and video connections. The use of a laptop or desk computer is preferred to minimize camera movement.

Physical examination – The physical examination is typically more focused and limited but includes a global visual assessment of the patient throughout the telemedicine encounter. Resources to provide instruction on conducting virtual physical examinations are available.

Limitations of telemedicine – Telemedicine is popular with many patients due to ease of use, cost savings, and decrease in travel time. However, it also has several limitations, including the inability to conduct an in-person physical examination and the diminution of many traditional "doctoring" elements, such as touch, physical presence, and emotional connection. Telemedicine visits may not be available to all patients due to limited internet access or difficulties with accessing and utilizing technology.

Telemedicine in primary and specialty care – In primary care, telemedicine encounters can be utilized for a variety of visits; in addition to urgent care visits, telemedicine can be used for chronic disease management, including diabetes, mental health, heart failure, chronic obstructive pulmonary disease (COPD), and obesity. Information from remote patient monitoring equipment (eg, glucometers, blood pressure monitors, scales, oximeters, noninvasive ventilation equipment for sleep apnea) can also be transmitted to the provider or, in some cases, uploaded to the patient's electronic medical record automatically. Telemedicine is also being used in cardiology, endocrinology, hepatology, nephrology, neurology, mental health, ophthalmology, dermatology, and surgical perioperative care management.

Benefit Application

BlueCard/National Account Issues

Benefits are determined by the group contract, member benefit booklet, and/or individual subscriber certificate in effect at the time services were rendered. Benefit products or negotiated coverages may have all or some of the services discussed in this medical policy excluded from their coverage.

Background

Telemedicine systems allow the evaluation and monitoring of the patient's condition remotely. The devices collect physiological data through physicians in the periphery (blood pressure / pulse measurements, ECG, temperature, weight, pulse oximetry, glucose determination and PT / INR devices) and transmit the information to an agency through of telephone lines or wireless computer networks. These medical services do not involve direct contact with the patient. Telehealth services are live, interactive audio and visual transmissions of a doctor-patient encounter from one place to another using telecommunications technologies. This may include real-time telecommunications transmissions or those transmitted by storage and forwarding technology. E-visits (email and / or online medical evaluations) refers to the ability of health providers to interact with patients through a secure electronic channel
 

Regulatory Status

 Please refer to the Table of codes that includes some of the codes of procedures approved by virtue of the dipositions of the law and applicable regulations for the use of Telemedicine.  Evolving telemedicine regulatory issues – Regulatory issues surrounding the delivery of telemedicine services vary regionally and by country and are rapidly evolving. Providers should ensure that their delivery platform(s), coding, billing, licensure, and prescribing practices are compliant with regulatory requirements and provide adequate security. Regulations regarding prescriptions may also vary.

Rationale

Promotion of greater diversity and inclusion in clinical research of historically marginalized groups (e.g., People of Color [African-American, Asian, Black, Latino and Native American]; LGBTQIA (Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, Asexual); Women; and People with Disabilities [Physical and Invisible]) allows policy populations to be more reflective of and findings more applicable to our diverse members. While we also strive to use inclusive language related to these groups in our policies, use of gender-specific nouns (e.g., women, men, sisters, etc.) will continue when reflective of language used in publications describing study populations.

Population Reference No. 1 

Individuals of all populations. Interventions of interest are telemidicine consultation. Comparators of interest are standard in-person consultation. Relevant outcomes include

overall quality of care, quality of life and patient satisfaction.

Population Reference No. 1 Policy Statement

[X] MedicallyNecessary [ ] Investigational

Supplemental Information

N/A

Practice Guidelines and Position Statements

N/A

Medicare National Coverage

N/A

References

  1. Dwyer TF. Telepsychiatry: psychiatric consultation by interactive television. Am J Psychiatry 1973; 130:865.
  2. Mermelstein H, Guzman E, Rabinowitz T, et al. The application of technology to health: The evolution of telephone to telemedicine and telepsychiatry: A historical review and look at human factors. J Technol Behav Sci 2017; 2:5.
  3. Weinstein RS, Lopez AM, Joseph BA, et al. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med 2014; 127:183.
  4. Humphreys J, Schoenherr L, Elia G, et al. Rapid Implementation of Inpatient Telepalliative Medicine Consultations During COVID-19 Pandemic. J Pain Symptom Manage 2020; 60:e54.
  5. Office of the National Coordinator for Health Information Technology. What is telehealth? How is telehealth different from telemedicine? Available at: https://www.healthit.gov/faq/what-telehealth-how-telehealth-different-telemedicine (Accessed on May 26, 2020).
  6. Kvedar J, Coye MJ, Everett W. Connected health: a review of technologies and strategies to improve patient care with telemedicine and telehealth. Health Aff (Millwood) 2014; 33:194.
  7. Daskivich LP, Vasquez C, Martinez C Jr, et al. Implementation and Evaluation of a Large-Scale Teleretinal Diabetic Retinopathy Screening Program in the Los Angeles County Department of Health Services. JAMA Intern Med 2017; 177:642.
  8. Zakaria A, Maurer T, Su G, Amerson E. Impact of teledermatology on the accessibility and efficiency of dermatology care in an urban safety-net hospital: A pre-post analysis. J Am Acad Dermatol 2019; 81:1446.
  9. Vegesna A, Tran M, Angelaccio M, Arcona S. Remote Patient Monitoring via Non-Invasive Digital Technologies: A Systematic Review. Telemed J E Health 2017; 23:3.
  10. Center for Connected Health Policy. State telehealth laws and reimbursement policies report, fall 2022. Available: https://www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2022/ (Accessed on February 08, 2023).
  11. Calton B, Abedini N, Fratkin M. Telemedicine in the Time of Coronavirus. J Pain Symptom Manage 2020; 60:e12.
  12. Benziger CP, Huffman MD, Sweis RN, Stone NJ. The Telehealth Ten: A Guide for a Patient-Assisted Virtual Physical Examination. Am J Med 2021; 134:48.
  13. Laskowski ER, Johnson SE, Shelerud RA, et al. The Telemedicine Musculoskeletal Examination. Mayo Clin Proc 2020; 95:1715.
  14. Eble SK, Hansen OB, Ellis SJ, Drakos MC. The Virtual Foot and Ankle Physical Examination. Foot Ankle Int 2020; 41:1017.
  15. Wilson AM, Ong MK, Saliba D, Jamal NI. The Veterans Affairs Neuropathy Scale: A Reliable, Remote Polyneuropathy Exam. Front Neurol 2019; 10:1050.
  16. Soldatova L, Williams C, Postma GN, et al. Virtual Dysphagia Evaluation: Practical Guidelines for Dysphagia Management in the Context of the COVID-19 Pandemic. Otolaryngol Head Neck Surg 2020; 163:455.
  17. Uscher-Pines L, Mehrotra A. Analysis of Teladoc use seems to indicate expanded access to care for patients without prior connection to a provider. Health Aff (Millwood) 2014; 33:258.
  18. Liaw WR, Jetty A, Coffman M, et al. Disconnected: a survey of users and nonusers of telehealth and their use of primary care. J Am Med Inform Assoc 2019; 26:420.
  19. Singh GK, Siahpush M. Widening rural-urban disparities in life expectancy, U.S., 1969-2009. Am J Prev Med 2014; 46:e19.
  20. Esteban C, Moraza J, Iriberri M, et al. Outcomes of a telemonitoring-based program (telEPOC) in frequently hospitalized COPD patients. Int J Chron Obstruct Pulmon Dis 2016; 11:2919.
  21. Bashshur RL, Shannon GW, Smith BR, et al. The empirical foundations of telemedicine interventions for chronic disease management. Telemed J E Health 2014; 20:769.
  22. Davis AM, Sampilo M, Gallagher KS, et al. Treating rural paediatric obesity through telemedicine vs. telephone: Outcomes from a cluster randomized controlled trial. J Telemed Telecare 2016; 22:86.
  23. Lee JY, Lee SWH. Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review. Diabetes Technol Ther 2018; 20:492.
  24. McDonnell ME. Telemedicine in Complex Diabetes Management. Curr Diab Rep 2018; 18:42.
  25. Bellsmith KN, Gale MJ, Yang S, et al. Validation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era. JAMA Ophthalmol 2022; 140:465.
  26. Kuziemsky C, Maeder AJ, John O, et al. Role of Artificial Intelligence within the Telehealth Domain. Yearb Med Inform 2019; 28:35.
  27. Su D, Zhou J, Kelley MS, et al. Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract 2016; 116:136.
  28. Faruque LI, Wiebe N, Ehteshami-Afshar A, et al. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. CMAJ 2017; 189:E341.
  29. Carlson AL, Martens TW, Johnson L, Criego AB. Continuous Glucose Monitoring Integration for Remote Diabetes Management: Virtual Diabetes Care with Case Studies. Diabetes Technol Ther 2021; 23:S56.
  30. Bergenstal RM, Layne JE, Zisser H, et al. Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic. Diabetes Technol Ther 2021; 23:128.
  31. Polisena J, Tran K, Cimon K, et al. Home telemonitoring for congestive heart failure: a systematic review and meta-analysis. J Telemed Telecare 2010; 16:68.
  32. Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010; :CD007228.
  33. Ong MK, Romano PS, Edgington S, et al. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med 2016; 176:310.
  34. Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010; 363:2301.
  35. Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012; 125:2985.
  36. Barnett ML, Ray KN, Souza J, Mehrotra A. Trends in Telemedicine Use in a Large Commercially Insured Population, 2005-2017. JAMA 2018; 320:2147.
  37. Arevian AC, Jeffrey J, Young AS, Ong MK. Opportunities for Flexible, On-Demand Care Delivery Through Telemedicine. Psychiatr Serv 2018; 69:5.
  38. Ong MK, Brotman DJ. The Virtual Hospitalist: The Future is Now. J Hosp Med 2018; 13:798.
  39. Wosik J, Fudim M, Cameron B, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc 2020; 27:957.
  40. Kakani P, Sorensen A, Quinton JK, et al. Patient Characteristics Associated with Telemedicine Use at a Large Academic Health System Before and After COVID-19. J Gen Intern Med 2021; 36:1166.
  41. Eberly LA, Kallan MJ, Julien HM, et al. Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic. JAMA Netw Open 2020; 3:e2031640.
  42. Centers for Disease Control and Prevention. Telehealth and telemedicine during COVID-19 in low resource non-US settings. Available: https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/telehealth-covid19-nonus.html (Accessed on February 08, 2023).
  43. Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation 2020; 141:e823.
  44. Kuperman EF, Linson EL, Klefstad K, et al. The Virtual Hospitalist: A Single-Site Implementation Bringing Hospitalist Coverage to Critical Access Hospitals. J Hosp Med 2018; 13:759.
  45. Flint L, Kotwal A. The New Normal: Key Considerations for Effective Serious Illness Communication Over Video or Telephone During the Coronavirus Disease 2019 (COVID-19) Pandemic. Ann Intern Med 2020; 173:486.
  46. Dorsey ER, Topol EJ. State of Telehealth. N Engl J Med 2016; 375:154.
  47. Verghese A. Culture shock--patient as icon, icon as patient. N Engl J Med 2008; 359:2748.
  48. Fischer SH, Ray KN, Mehrotra A, et al. Prevalence and Characteristics of Telehealth Utilization in the United States. JAMA Netw Open 2020; 3:e2022302.
  49. Ramirez AV, Ojeaga M, Espinoza V, et al. Telemedicine in Minority and Socioeconomically Disadvantaged Communities Amidst COVID-19 Pandemic. Otolaryngol Head Neck Surg 2021; 164:91.
  50. Reed ME, Huang J, Graetz I, et al. Patient Characteristics Associated With Choosing a Telemedicine Visit vs Office Visit With the Same Primary Care Clinicians. JAMA Netw Open 2020; 3:e205873.
  51. Frydman JL, Li W, Gelfman LP, Liu B. Telemedicine Uptake Among Older Adults During the COVID-19 Pandemic. Ann Intern Med 2022; 175:145.
  52. Pew Research Center. Internet/broadband fact sheet. Available at: https://www.pewresearch.org/internet/fact-sheet/internet-broadband/ (Accessed on February 08, 2023).
  53. Pew Research Center. Digital divide persists even as lower-income Americans make gains in tech adoption. Available at: https://pewresearch-org-preprod.go-vip.co/fact-tank/2021/06/22/digital-divide-persists-even-as-americans-with-lower-incomes-make-gains-in-tech-adoption/ (Accessed on February 08, 2023).
  54. Lam K, Lu AD, Shi Y, Covinsky KE. Assessing Telemedicine Unreadiness Among Older Adults in the United States During the COVID-19 Pandemic. JAMA Intern Med 2020; 180:1389.
  55. Nieman CL, Oh ES. Connecting With Older Adults via Telemedicine. Ann Intern Med 2020; 173:831.
  56. Roberts ET, Mehrotra A. Assessment of Disparities in Digital Access Among Medicare Beneficiaries and Implications for Telemedicine. JAMA Intern Med 2020; 180:1386.
  57. Romano MF, Sardella MV, Alboni F, et al. Is the digital divide an obstacle to e-health? An analysis of the situation in Europe and in Italy. Telemed J E Health 2015; 21:24.
  58. Reiners F, Sturm J, Bouw LJW, Wouters EJM. Sociodemographic Factors Influencing the Use of eHealth in People with Chronic Diseases. Int J Environ Res Public Health 2019; 16.
  59. Hong YA, Zhou Z, Fang Y, Shi L. The Digital Divide and Health Disparities in China: Evidence From a National Survey and Policy Implications. J Med Internet Res 2017; 19:e317.
  60. Reed ME, Huang J, Parikh R, et al. Patient-Provider Video Telemedicine Integrated With Clinical Care: Patient Experiences. Ann Intern Med 2019; 171:222.
  61. Schumm MA, Pyo HQ, Ohev-Shalom R, et al. Patient experience with electronic health record-integrated postoperative telemedicine visits in an academic endocrine surgery program. Surgery 2021; 169:1139.
  62. Institute for Safe Medication Practices. Special edition medication safety alert: COVID-19-related medication errors. Available at: https://ismp.org/acute-care/special-edition-medication-safety-alert-may-14-2020/covid-19 (Accessed on February 08, 2023).
  63. Kruse CS, Krowski N, Rodriguez B, et al. Telehealth and patient satisfaction: a systematic review and narrative analysis. BMJ Open 2017; 7:e016242.
  64. Orlando JF, Beard M, Kumar S. Systematic review of patient and caregivers' satisfaction with telehealth videoconferencing as a mode of service delivery in managing patients' health. PLoS One 2019; 14:e0221848.
  65. Shah VV, Villaflores CW, Chuong LH, et al. Association Between In-Person vs Telehealth Follow-up and Rates of Repeated Hospital Visits Among Patients Seen in the Emergency Department. JAMA Netw Open 2022; 5:e2237783.
  66. Evidence Brief: Video Telehealth for Primary Care and Mental Health Services, Veazie S, Bourne D, Peterson K, Anderson J. (Eds), Department of Veterans Affairs (US), Washington (DC) 2019.
  67. Croymans D, Hurst I, Han M. Telehealth: The right care, at the right time, via the right medium. NEJM Catal Innov Care Deliv 2020.
  68. Mechanic OJ, Lee EM, Sheehan HM, et al. Evaluation of Telehealth Visit Attendance After Implementation of a Patient Navigator Program. JAMA Netw Open 2022; 5:e2245615.
  69. Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses. J Med Internet Res 2020; 22:e16791.
  70. Inglis SC, Clark RA, Dierckx R, et al. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015; 2015:CD007228.
  71. Ashwood JS, Mehrotra A, Cowling D, Uscher-Pines L. Direct-To-Consumer Telehealth May Increase Access To Care But Does Not Decrease Spending. Health Aff (Millwood) 2017; 36:485.
  72. Martinez KA, Rood M, Jhangiani N, et al. Association Between Antibiotic Prescribing for Respiratory Tract Infections and Patient Satisfaction in Direct-to-Consumer Telemedicine. JAMA Intern Med 2018; 178:1558.
  73. Ray KN, Shi Z, Gidengil CA, et al. Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits. Pediatrics 2019; 143.
  74. Accreditation Council for Graduate Medical Education. Specialty-specific program requirements: Direct supervision using telecommunication technology. Available at: https://www.acgme.org/globalassets/PDFs/Specialty-specific-Requirement-Topics/DIO-Direct_Supervision_Telecommunication.pdf (Accessed on February 08, 2023).
  75. Physicians and other clinicians: CMS flexibilities to fight COVID-19. Centers for Medicare & Medicaid Services. https://www.cms.gov/files/document/physicians-and-other-clinicians-cms-flexibilities-fight-covid-19.pdf (Accessed on August 18, 2023).
  76. Zheng F, Park KW, Thi WJ, et al. Financial implications of telemedicine visits in an academic endocrine surgery program. Surgery 2019; 165:617.
  77. Telehealth policy changes after the COVID-19 public health emergency. US Department of Health and Human Services. https://telehealth.hhs.gov/providers/telehealth-policy/policy-changes-after-the-covid-19-public-health-emergency (Accessed on August 18, 2023).
  78. Centers for Medicare and Medicaid Services. Medicare telemedicine snapshot - December 2021 FAQs. https://www.cms.gov/files/document/medicare-telemedicine-snapshot-faqs.pdf (Accessed on February 08, 2023).
  79. Center for Connected Health Policy. Cross-state licensing. Available at: https://www.cchpca.org/topic/cross-state-licensing-professional-requirements/ (Accessed on February 08, 2023).
  80. Interstate Medical Licensure Compact Commission. Available at: https://www.imlcc.org/ (Accessed on February 08, 2023).
  81. US Congress. Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Available at: https://www.congress.gov/110/plaws/publ425/PLAW-110publ425.pdf (Accessed on February 08, 2023).
  82. Prescribing controlled substances via telehealth. US Department of Health and Human Services. https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth (Accessed on August 18, 2023).

Codes

Codes

Number

Description

CPT

 

99201

Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self-limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.

 

99202

Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 20 minutes are spent face-to-face with the patient and/or family.

 

99203

Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A detailed history; A detailed examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate severity. Typically, 30 minutes are spent face-to-face with the patient and/or family.

 

99204

Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.

 

99205

Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 60 minutes are spent face-to-face with the patient and/or family.

 

99212

Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self-limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.

 

99213

Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.

 

99214

Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.

 

99215

Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 40 minutes are spent face-to-face with the patient and/or family.

 

99441

Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

 

99442

Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion    

 

99443

Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion    

 

99446

Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician, including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 5-10 minutes of medical consultative discussion and review

 

99447

Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician, including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 11-20 minutes of medical consultative discussion and review

 

99448

Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician, including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 21-30 minutes of medical consultative discussion and review

 

99449

Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician, including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 31 minutes or more of medical consultative discussion and review

 

99451

Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time

 

99452

Interprofessional telephone/Internet/electronic health record referral service(s) provided by a treating/requesting physician or other qualified health care professional, 30 minutes
 

90791

Psychiatric diagnostic evaluation    
 

90792

Psychiatric diagnostic evaluation with medical services    
 

90832

Psychotherapy, 30 minutes with patient    

 

90833

Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)    

 

90834

Psychotherapy, 45 minutes with patient    

 

90836

Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)    

 

90837

Psychotherapy, 60 minutes with patient    

 

90838

Psychotherapy, 60 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)    

HCPCS

G0425

Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth

 

G0426

Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth

 

G0427

Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more

communicating with the patient via telehealth

 

G0406

Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth

 

G0407

Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth

 

G0408

Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth

 

G2010

Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment
 

G2012

Brief communication technology-based service, e.g., virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

 

T1014

Telehealth transmission, per minute, professional services bill separately

ICD-10 CM

 

 

applies all diagnoses

Applicable Modifiers

N/A

Policy History

Date

Action

Description

10/24/2024 Policy Review Literature review current through: October 2024. No changes on statements. Reviwed by the Providers Advisory Committee.
10/26/2023 Policy Review

Reviewed by the Providers Advisory Committee. No changes in policy statement. 

11/09/2022

Annual Review

Reviewed by the Providers Advisory Committee. No changes in policy statement. 

11/10/2021 Annual Review

Reviewed by the Providers Advisory Committee. Policy Statement no changes

11/11/2020

Policy Reviewed

Reviewed by the Providers Advisory Committee. No changes

7/03/2020    

Policy reviewd    

CPT codes added.

11/14/2019

Policy reviewed

Policy reviewed by the Providers Advisory Committee.  No changes.

11/14/2018

Policy reviewed.  

New Format.

Policy reviewed by the Providers Advisory Committee.  A recommendation of using telemedicine to have a final assetment for patients with uncontrolled hypertension was given.  Policy is open to any acute diagnosis, not life threathening. 

12/29/2017

Policy reviewed

 

06/28/2016

Policy reviewed

 

08/14/2014

Policy reviewed

 

12/18/2013

Policy created

New policy